(Q46815330)

25 December 2017

title

Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure (English)

1 reference

25 December 2017

invasive fungal infections

1 reference

1 reference

1 reference

J-H Weitkamp

1

1 reference

25 December 2017

A Ozdas

series ordinal

2

1 reference

25 December 2017

B LaFleur

series ordinal

3

1 reference

25 December 2017

A L Potts

series ordinal

4

1 reference

25 December 2017

publication date

10 January 2008

1 reference

25 December 2017

published in

Journal of Perinatology

1 reference

25 December 2017

volume

28

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

405-411

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.jp.7211914

exact match

0 references

cites work

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Risk factors for candidemia in critically ill infants: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole prophylaxis against fungal colonization and infection in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fungal chemoprophylaxis with fluconazole in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole for the prevention of fungal infections: get ready, get set, caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Risk factors for Candida species colonization of neonatal intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Excess costs of hospital care associated with neonatal candidemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Antifungal agents for preventing fungal infections in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Safety and tolerability of fluconazole in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Identifiers

DOI

10.1038/SJ.JP.7211914

1 reference

25 December 2017

PubMed ID

18185518

1 reference

25 December 2017